Online Program

339589
Medication Therapy Management (MTM): Implications for Public Health Workforce Development


Tuesday, November 3, 2015 : 9:10 a.m. - 9:30 a.m.

Polly Turner, DrPH, MPH, RPH, College of Pharmacy and Health Sciencss, Retired from Texas Southern University, Houston, TX
The older population, persons 65 years or older, is growing significantly in the United States.  U. S. Census reports show that U.S. older population numbered 44.7 million in 2013 (the latest year for which data is available).  Further, this population is projected to continue its growth to about 98 million by 2060.  This is more than twice their number in 2013.  Further, people 65+ represent 14.1% of the population in 2013, but are expected to grow to be 21.7% by 2014.  The IOM 2008 report, Retooling for an Aging America: Building the Health Care Workforce, discusses the projected impact this growth will have on our health care system.  The report explained we will have a future workforce that is inadequate in its capacity to meet the large demand for health services for older adults if current patterns of care and of the training of providers continue.  The National Health Care Workforce Commission, established by the Patient Protection and Affordable Care Act (ACA) is designed to develop and implement strategic to address predicted shortages in health care personnel, especially in the areas of Medication Therapy Management services.


Learning Areas:

Provision of health care to the public
Public health or related education
Systems thinking models (conceptual and theoretical models), applications related to public health

Learning Objectives:
Discuss the impact of shortages health care providers for all people, especially older population. Discuss the value and importance of the National Health Care Workforce Commission. Explain the value of the United States Public Health Science.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: tba
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.